IEFM
PACB icon

IQ EQ Fund Management’s Pacific Biosciences PACB Stock Holding History

IQ EQ Fund Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Sell
1,694,546
-93,847
-5% -$136K 0.18% 125
2026
Q1 		$2.36M Sell
1,788,393
-106,538
-6% -$191K 0.18% 130
2025
Q4 		$3.54M Buy
1,894,931
+606,239
+47% +$1.16M 0.24% 106
2025
Q3 		$1.65M Buy
1,288,692
+499,421
+63% +$676K 0.11% 163
2025
Q2 		$979K Buy
789,271
+471,101
+148% +$544K 0.09% 208
2025
Q1 		$375K Buy
318,170
+154,688
+95% +$237K 0.04% 253
2024
Q4 		$299K Buy
163,482
+96,118
+143% +$188K 0.04% 256
2024
Q3 		$115K Buy
67,364
+23,619
+54% +$38.8K 0.01% 313
2024
Q2 		$59.9K Buy
+43,745
New +$88.3K 0.01% 307

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IQ EQ Fund Management's PACB Position: Q2 2026 in Review

IQ EQ Fund Management reduced its Pacific Biosciences (PACB) stake by 5.2% in Q2 2026, selling an estimated $136K and leaving 1,694,546 shares worth $2.85M. The position accounts for 0.18% of the portfolio, ranked #125.

IQ EQ Fund Management first reported a position in PACB in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.54M in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • IQ EQ Fund Management held 1,694,546 shares of Pacific Biosciences worth $2.85M as of Q2 2026.
  • IQ EQ Fund Management sold 93,847 Pacific Biosciences shares in Q2 2026, an estimated $136K.
  • Pacific Biosciences made up 0.18% of IQ EQ Fund Management's portfolio in Q2 2026, its #125 holding.
  • IQ EQ Fund Management first reported a position in Pacific Biosciences in Q2 2024 and has held it in 9 quarters since.
  • IQ EQ Fund Management's Pacific Biosciences position peaked at $3.54M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.